Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Benefits of Judicial Assistance Dogs for Child Victims in Child Advocacy and Pediatric Assessment Units (UAPEDs) (AudiCAJ)

3. september 2026 oppdatert av: Centre Hospitalier Régional d'Orléans

Child maltreatment is common and encompasses various forms, including psychological, physical, and sexual abuse, exposure to domestic violence, neglect, and sexual exploitation. Each year, French police and gendarmerie services record more than 50,000 child victims of intrafamilial violence, according to data from the Ministerial Statistical Service for Internal Security (SSMSI). Approximately two-thirds of these children are victims of physical violence and one-third are victims of sexual violence. These figures have increased steadily over recent years, particularly for sexual violence, in the context of greater disclosure by victims. Violence against children constitutes a major public health issue because of its short- and long-term physical, psychological, and developmental consequences, as well as the increased risk of involvement in future violence during adolescence or adulthood, either as victims or perpetrators.

Children presumed to be victims of abuse are managed in Child Advocacy and Pediatric Assessment Units (Unités d'Accueil Pédiatrique Enfance en Danger, UAPEDs) by multidisciplinary teams comprising physicians, psychologists, nurses, and social workers, following judicial referral or concerns raised by parents or caregivers. Depending on the circumstances, the child may undergo a forensic interview conducted on-site by law enforcement officers (police or gendarmerie), followed by a medico-legal and/or psychological assessment to evaluate the impact of the alleged abuse. This model enables comprehensive care to be delivered in a single location and within a limited timeframe, with professionals working around the child, thereby minimizing repeated disclosures and reducing the risk of retraumatization. The vast majority of forensic interviews are conducted by investigators trained in the National Institute of Child Health and Human Development (NICHD) protocol for interviewing children.

It has been hypothesized that the involvement of a Judicial Assistance Dog (JAD) may provide benefits to children during forensic interviews, a key stage of the judicial process that can be highly stressful for child victims of abuse who are asked to recount traumatic experiences to an unfamiliar investigator.

For centuries, dogs have been domesticated to accompany humans. Since the late twentieth century, they have been specifically trained to assist vulnerable individuals, support people with chronic conditions, and participate in animal-assisted interventions. The role of dogs as part of healthcare and psychosocial support has been extensively studied in recent years. Animal-assisted interventions have been used in a variety of clinical settings with the aim of reducing anxiety, pain, and stress-related symptoms through mechanisms involving emotional regulation and attentional processes. Several studies have reported benefits among children with mental health conditions, including post-traumatic stress disorder (PTSD), depression, attention-deficit/hyperactivity disorder (ADHD), anxiety disorders, and problematic video gaming behaviors. Assistance dogs are also frequently incorporated into interventions for children with autism spectrum disorder to promote prosocial behaviors, with beneficial interactions observed regardless of the child's verbal communication abilities. In pediatric hospital settings, animal-assisted therapy has been associated with reductions in both blood pressure and pain levels.

These effects may be mediated by physiological mechanisms. Exposure to a dog for 15 minutes has been associated with significant reductions in cortisol levels (13), while human-dog interactions have also been linked to changes in electroencephalographic activity and heart rate, potentially enhancing shared attention and emotional regulation.

The concept of the Judicial Assistance Dog first emerged in the United States in the early 2000s within court settings. In France, following a model similar to that developed in North America, the first Judicial Assistance Dog, named Lol, joined the Cahors Court of Justice in 2019 to support victims throughout judicial proceedings. Orko, the second Judicial Assistance Dog trained in France, joined the Child Advocacy and Pediatric Assessment Unit of Orléans University Hospital in 2020.

Several potential benefits of Judicial Assistance Dogs during forensic interviews have been suggested, including reductions in signs of distress and anxiety among child victims. A study conducted in the United States demonstrated significant decreases in heart rate and blood pressure among presumed child victims of sexual abuse who were accompanied by an assistance dog during the forensic process.

Studieoversikt

Detaljert beskrivelse

This study aims to measure the anxious state of the minor when he first arrives at the unit (T0) and 10 minutes later (T1) with or without the presence of a Judicial Assistance Dog (JAD).

The minor is randomized in one of the two groups of the study:

  • the interventional group (minor in the dedicated waiting room with the JAD for 10min)
  • or the control group (minor in the dedicated waiting room without the JAD for 10min).

Then an anxiety measure occurs. Two time point are evaluated: at arrival (T0) and after waiting 10min (T1):

  1. Anxiety questionnaire: STAI-C translated in French answered with the help of a registered nurse trained for psychometric tests (10 min)
  2. Anxiety level self-assessment (2 min)
  3. Cardiac frequency measure by the registered nurse in charge of the minor (5 min): an average of 3 measures will be taken

Studietype

Intervensjonell

Registrering (Antatt)

46

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

      • Orléans, Frankrike, 45067
        • Centre Hospitalier Universitaire d'Orléans

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  1. First-time interview in a child advocacy and pediatric assessment unit (UAPED)
  2. Age ≥ 7 years
  3. Ability to understand and complete the Stat-trait Anxiety Inventory for Children (STAI-C)
  4. Written informed consent obtained from the child's legal guardian

Exclusion Criteria:

  1. Previous contact with the Judicial Assistant Dog
  2. Known dog allergy
  3. Lack of informed consent from the legal guardian
  4. Lack of assent from the child

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Judicial Assistance Dog group
Children assigned to this group will have contact with the Judicial Assistance Dog before the forensic interview.
After randomization, the Judicial Assistance Dog will be introduced to the child in the waiting room, and the child will remain in contact with the dog for 10 minutes.
Ingen inngripen: Standard waiting room group
Children assigned to this group will undergo the standard pre-interview waiting period without contact with the Judicial Assistance Dog.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
To evaluate the effect of the presence of a Judicial Assistance Dog on the chil's anxiety level prior to the forensic interview.
Tidsramme: At T0: Baseline assessment upon arrival At T1: After 10 minutes of waiting
Comparison of the change in STAI-C scores between T1 (after 10 min of waiting) and T0 (baseline assessment upon arrival) between the intervention group (10-minute exposure to the Judicial Assistance Dog) and the control group (10 minutes in a standard waiting room)
At T0: Baseline assessment upon arrival At T1: After 10 minutes of waiting

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
To evaluate the effect of the presence of a Judicial Assistance Dog on heart rate
Tidsramme: At T0: Baseline assessment upon arrival At T1: After 10 minutes of waiting
Comparison of the change in heart rate (beats per minute, bpm) between T1 (after 10 minutes of waiting) and T0 (baseline assessment upon arrival) between the intervention group (10-minute exposure to the judicial assistant dog) and the control group (10 minutes in a standard waiting room)
At T0: Baseline assessment upon arrival At T1: After 10 minutes of waiting
To evaluate the effect of the presence of a Judicial Assistance Dog on perceived anxiety
Tidsramme: At T0: Baseline assessment upon arrival At T1: After 10 minutes of waiting
Comparison of the change in score on the Anxiety Level Self-Assessment Scale between T1 (after 10 minutes of waiting) and T0 (baseline assessment upon arrival) between the intervention group (10-minute exposure to the judicial assistant dog) and the control group (10 minutes in a standard waiting room).
At T0: Baseline assessment upon arrival At T1: After 10 minutes of waiting

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Sarah EID, Doctor, Centre Hospitalier Universitaire d'Orléans

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. oktober 2026

Primær fullføring (Antatt)

1. april 2028

Studiet fullført (Antatt)

1. april 2028

Datoer for studieregistrering

Først innsendt

3. september 2026

Først innsendt som oppfylte QC-kriteriene

3. september 2026

Først lagt ut (Faktiske)

10. september 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

10. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

3. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere